The Marijuana Herald - Marijuana news and information A new study found that cannabidiol (CBD) reduced the expression of a key receptor that drives HER2-positive breast cancer while activating cellular stress pathways and increasing cancer cell death. The effects were also examined when CBD was combined with the breast cancer drug trastuzumab. The study, accepted for publication August 10 in BMC Complementary Medicine and Therapies, was conducte…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.